Chronic Fatigue Therapy
NDC 17312-170, EPINEPHRINE, GOLD, CHELIDONIUM MAJUS, ECHINACEA, GINKGO, HELLEBORUS NIGER, PHOSPHORIC ACID, SCUTELLARIA LATERIFLORA, THUJA OCCIDENTALIS, tablet, orally disintegrating, from TRP Company.
- Product NDC
- 17312-170
- Status
- Listed
- Labeler
- TRP Company
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17312-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SCUTELLARIA LATERIFLORA6 [hp_X]/1
- THUJA OCCIDENTALIS LEAFY TWIG6 [hp_X]/1
- GINKGO3 [hp_X]/1
- CHELIDONIUM MAJUS6 [hp_X]/1
- EPINEPHRINE7 [hp_X]/1
- PHOSPHORIC ACID6 [hp_X]/1
- ECHINACEA, UNSPECIFIED3 [hp_X]/1
- GOLD8 [hp_X]/1
- HELLEBORUS NIGER ROOT6 [hp_X]/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17312-170-14 | 17312017014 | 1 BOTTLE in 1 PACKAGE (17312-170-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 17312-170 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17312-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17312-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.